The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Donald J. Buchsbaum

Department of Radiation Oncology

University of Alabama at Birmingham

1825 University Boulevard

Shelby

[email]@uab.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Radiation Oncology, University of Alabama at Birmingham, 1825 University Boulevard, Shelby. 1999 - 2011
  • Department of Radiation Oncology, Division of Radiation Biology, 1530 3rd Avenue South, WT1 674, USA. 2007
  • University of Alabama at Birmingham, Comprehensive Cancer Center, Department of Radiation Oncology, 1824 6th Avenue South, USA. 2006

References

  1. Mechanisms of Drug Sensitization to TRA-8, an Agonistic Death Receptor 5 Antibody, Involve Modulation of the Intrinsic Apoptotic Pathway in Human Breast Cancer Cells. Amm, H.M., Zhou, T., Steg, A.D., Kuo, H., Li, Y., Buchsbaum, D.J. Mol. Cancer Res. (2011) [Pubmed]
  2. TRAIL-receptor antibodies as a potential cancer treatment. Buchsbaum, D.J., Forero-Torres, A., LoBuglio, A.F. Future. Oncol (2007) [Pubmed]
  3. TRAIL receptor-targeted therapy. Buchsbaum, D.J., Zhou, T., Lobuglio, A.F. Future. Oncol (2006) [Pubmed]
  4. Radiotargeted gene therapy. Buchsbaum, D.J., Chaudhuri, T.R., Zinn, K.R. J. Nucl. Med. (2005) [Pubmed]
  5. Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein. Buchsbaum, D.J., Khazaeli, M.B., Axworthy, D.B., Schultz, J., Chaudhuri, T.R., Zinn, K.R., Carpenter, M., LoBuglio, A.F. Clin. Cancer Res. (2005) [Pubmed]
  6. Gene expression imaging with radiolabeled peptides. Buchsbaum, D.J., Chaudhuri, T.R., Yamamoto, M., Zinn, K.R. Ann. Nucl. Med (2004) [Pubmed]
  7. Invited commentary: targeting of 125I-labeled B lymphocyte stimulator. Buchsbaum, D.J., LoBuglio, A.F. J. Nucl. Med. (2003) [Pubmed]
  8. Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model. Buchsbaum, D.J., Zhou, T., Grizzle, W.E., Oliver, P.G., Hammond, C.J., Zhang, S., Carpenter, M., LoBuglio, A.F. Clin. Cancer Res. (2003) [Pubmed]
  9. Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiation. Buchsbaum, D.J., Bonner, J.A., Grizzle, W.E., Stackhouse, M.A., Carpenter, M., Hicklin, D.J., Bohlen, P., Raisch, K.P. Int. J. Radiat. Oncol. Biol. Phys. (2002) [Pubmed]
  10. Gene therapy for the treatment of cancer. Buchsbaum, D.J., Curiel, D.T. Cancer Biother. Radiopharm. (2001) [Pubmed]
  11. Gene transfer strategies for improving radiolabeled peptide imaging and therapy. Rogers, B.E., Zinn, K.R., Buchsbaum, D.J. Q. J. Nucl. Med (2000) [Pubmed]
  12. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model. Buchsbaum, D.J., Khazaeli, M.B., Mayo, M.S., Roberson, P.L. Clin. Cancer Res. (1999) [Pubmed]
 
WikiGenes - Universities